Holen Sie sich die Stockscreener-App
1.02
0.99%
0.01
Handel nachbörslich:
.98
-0.04
-3.92%
Schlusskurs vom Vortag:
$1.01
Offen:
$0.99
24-Stunden-Volumen:
535.31K
Relative Volume:
0.71
Marktkapitalisierung:
$86.47M
Einnahmen:
$153.73M
Nettoeinkommen (Verlust:
$-106.79M
KGV:
-0.573
EPS:
-1.78
Netto-Cashflow:
$-115.93M
1W Leistung:
+13.92%
1M Leistung:
+23.32%
6M Leistung:
-28.17%
1J Leistung:
-76.17%
1-Tages-Spanne:
$0.95
$1.04
1-Wochen-Bereich:
$0.85
$1.07
52-Wochen-Spanne:
$0.5231
$4.80
Sutro Biopharma Inc Stock (STRO) Company Profile
Firmenname
Sutro Biopharma Inc
Sektor
Branche
Telefon
650-392-8412
Adresse
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Vergleichen Sie STRO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STRO
Sutro Biopharma Inc
|
1.02 | 80.62M | 153.73M | -106.79M | -115.93M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-16 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-03-17 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-03-14 | Herabstufung | BofA Securities | Buy → Underperform |
| 2025-03-14 | Herabstufung | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2025-03-14 | Herabstufung | Wedbush | Outperform → Neutral |
| 2024-05-08 | Eingeleitet | BofA Securities | Buy |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-06 | Eingeleitet | Oppenheimer | Outperform |
| 2023-03-21 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-08-18 | Fortgesetzt | Wells Fargo | Overweight |
| 2021-06-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-12-03 | Eingeleitet | Stifel | Buy |
| 2020-09-02 | Eingeleitet | Jefferies | Buy |
| 2020-07-16 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-13 | Eingeleitet | SunTrust | Buy |
| 2019-10-07 | Eingeleitet | BTIG Research | Buy |
| 2019-07-18 | Eingeleitet | Deutsche Bank | Buy |
| 2019-04-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-10-22 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2018-10-22 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-10-22 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Sutro Biopharma Inc Aktie (STRO) Neueste Nachrichten
What indicators show strength in Sutro Biopharma Inc.Market Activity Report & Weekly Chart Analysis and Guides - Newser
What’s the outlook for Sutro Biopharma Inc.’s sectorJuly 2025 Analyst Calls & High Accuracy Swing Trade Signals - khodrobank.com
Can you recover from losses in Sutro Biopharma Inc.2025 Biggest Moves & Step-by-Step Swing Trade Plans - Newser
Reversal indicators forming on Sutro Biopharma Inc. stockQuarterly Market Review & Fast Gaining Stock Reports - Newser
Is Sutro Biopharma Inc. reversing from oversold territory2025 Price Momentum & High Accuracy Swing Trade Signals - Newser
What is the Moat Score of Sutro Biopharma Inc.July 2025 Catalysts & Consistent Profit Trade Alerts - khodrobank.com
Measuring Sutro Biopharma Inc.’s beta against major indices2025 Market WrapUp & Free Risk Controlled Daily Trade Plans - Newser
Sutro Biopharma Inc. stock chart pattern explainedFed Meeting & Real-Time Buy Signal Alerts - Newser
Ranking Sutro Biopharma Inc. among high performing stocks via toolsAnalyst Downgrade & Precise Swing Trade Entry Alerts - Newser
What the charts say about Sutro Biopharma Inc. todayPortfolio Value Report & Safe Swing Trade Setups - Newser
Market reaction to Sutro Biopharma Inc.’s recent news2025 EndofYear Setup & Proven Capital Preservation Methods - Newser
Using data models to predict Sutro Biopharma Inc. stock movementMarket Movement Recap & Daily Oversold Stock Bounce Ideas - Newser
How institutional ownership impacts Sutro Biopharma Inc. stockWeekly Market Summary & Comprehensive Market Scan Insights - Newser
What is Sutro Biopharma Inc. s P E ratio telling usJuly 2025 Summary & Verified Short-Term Plans - khodrobank.com
How to recover losses in Sutro Biopharma Inc. stockJuly 2025 Selloffs & Free AI Powered Buy and Sell Recommendations - Newser
What machine learning models say about Sutro Biopharma Inc.July 2025 Trade Ideas & AI Enhanced Execution Alerts - Newser
Using data filters to optimize entry into Sutro Biopharma Inc.2025 Earnings Impact & Weekly High Momentum Picks - Newser
Real time breakdown of Sutro Biopharma Inc. stock performanceJuly 2025 Final Week & Pattern Based Trade Signal System - Newser
Using data tools to time your Sutro Biopharma Inc. exitJuly 2025 Trade Ideas & Smart Money Movement Alerts - Newser
Sutro Biopharma Inc. stock daily chart insightsEarnings Recap Report & Fast Moving Stock Watchlists - Newser
Is it time to cut losses on Sutro Biopharma Inc.2025 Market Overview & Comprehensive Market Scan Insights - Newser
Price action breakdown for Sutro Biopharma Inc.2025 Historical Comparison & Daily Entry Point Trade Alerts - Newser
What’s the recovery path for long term holders of Sutro Biopharma Inc.Portfolio Update Summary & Community Consensus Trade Alerts - Newser
Is Sutro Biopharma Inc. stock poised for growthJuly 2025 Snapshot & AI Powered Trade Plan Recommendations - Newser
Risk vs reward if holding onto Sutro Biopharma Inc.Buy Signal & Reliable Volume Spike Trade Alerts - Newser
Is Sutro Biopharma Inc. still worth holding after the dip2025 Geopolitical Influence & Verified Momentum Stock Watchlist - Newser
Investment Report: What is the target price for Sutro Biopharma Inc. stock2025 Trade Ideas & Risk Adjusted Buy/Sell Alerts - khodrobank.com
Using AI based signals to follow Sutro Biopharma Inc.Portfolio Value Report & Fast Moving Stock Trade Plans - Newser
What’s the MACD signal for Sutro Biopharma Inc.July 2025 Recap & Consistent Profit Trade Alerts - khodrobank.com
Block Trades: Is now the right time to enter Sutro Biopharma Inc.Jobs Report & Risk Managed Investment Signals - khodrobank.com
Sutro Biopharma Inc. Crosses 200 Day MA — Signal or NoiseJuly 2025 Analyst Calls & Smart Allocation Stock Tips - beatles.ru
Levels Update: Is now the right time to enter Sutro Biopharma Inc.2025 Stock Rankings & Safe Entry Point Identification - khodrobank.com
Published on: 2025-08-31 18:46:59 - Newser
Real time scanner hits for Sutro Biopharma Inc. explainedEarnings Miss & Low Drawdown Momentum Trade Ideas - Newser
Using fundamentals and technicals on Sutro Biopharma Inc.2025 Valuation Update & Fast Exit/Entry Strategy Plans - Newser
Will Sutro Biopharma Inc. price bounce be sustainableWeekly Trade Review & Free High Accuracy Swing Entry Alerts - Newser
Chartists See Breakout Potential in Sutro Biopharma Inc. getLinesFromResByArray error: size == 0 - newsyoung.net
Finanzdaten der Sutro Biopharma Inc-Aktie (STRO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Sutro Biopharma Inc-Aktie (STRO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Chung Jane | Chief Executive Officer |
Aug 09 '25 |
Option Exercise |
0.00 |
18,750 |
0 |
117,058 |
| ALBINI EDWARD C | CFO AND SECRETARY |
May 15 '25 |
Option Exercise |
0.00 |
44,719 |
0 |
176,800 |
| FITZPATRICK LINDA A | CHIEF PEOPLE & COMM. OFFICER |
May 01 '25 |
Option Exercise |
0.00 |
37,849 |
0 |
133,282 |
| Srinivasan Venkatesh | CHIEF TECH OP OFFICER |
May 01 '25 |
Option Exercise |
0.00 |
2,500 |
0 |
54,580 |
| Borgman Anne Elizabeth | CHIEF MEDICAL OFFICER |
May 01 '25 |
Option Exercise |
0.00 |
69,063 |
0 |
122,161 |
| Srinivasan Venkatesh | CHIEF TECH OP OFFICER |
Apr 11 '25 |
Option Exercise |
0.00 |
21,250 |
0 |
59,683 |
| NEWELL WILLIAM J | CEO |
Mar 05 '25 |
Option Exercise |
0.00 |
18,750 |
0 |
299,239 |
| FITZPATRICK LINDA A | CHIEF PEOPLE & COMM. OFFICER |
Mar 05 '25 |
Option Exercise |
0.00 |
8,750 |
0 |
99,027 |
| ALBINI EDWARD C | CFO AND SECRETARY |
Mar 05 '25 |
Option Exercise |
0.00 |
8,750 |
0 |
135,675 |
| FITZPATRICK LINDA A | CHIEF PEOPLE & COMM. OFFICER |
Mar 04 '25 |
Option Exercise |
0.00 |
9,125 |
0 |
94,025 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):